Cargando…
Analysis of the functional capacity outcome measures for myotonic dystrophy
OBJECTIVES: Defining clinically relevant outcome measures for myotonic dystrophy type 1 (DM1) that can be valid and feasible for different phenotypes has proven problematic. The Outcome Measures for Myotonic Dystrophy (OMMYD) group proposed a battery of functional outcomes: 6‐minute walk test, 30 se...
Autores principales: | Jimenez‐Moreno, Aura Cecilia, Nikolenko, Nikoletta, Kierkegaard, Marie, Blain, Alasdair P., Newman, Jane, Massey, Charlotte, Moat, Dionne, Sodhi, Jas, Atalaia, Antonio, Gorman, Grainne S., Turner, Chris, Lochmüller, Hanns |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689676/ https://www.ncbi.nlm.nih.gov/pubmed/31402614 http://dx.doi.org/10.1002/acn3.50845 |
Ejemplares similares
-
Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019) -
Analyzing walking speeds with ankle and wrist worn accelerometers in a cohort with myotonic dystrophy
por: Jimenez-Moreno, Aura Cecilia, et al.
Publicado: (2018) -
Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA)
por: DiPaolo, Giovanni, et al.
Publicado: (2017) -
Change over time in ability to perform activities of daily living in myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2020) -
The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research
por: Wood, Libby, et al.
Publicado: (2017)